Intravitreal Bevacizumab at 4-Month Intervals for Prevention of Macular Edema after Plaque Radiotherapy of Uveal Melanoma-Reference-Cited by-同舟云学术

Intravitreal Bevacizumab at 4-Month Intervals for Prevention of Macular Edema after Plaque Radiotherapy of Uveal Melanoma

Published:2014-01 Issue:1 Volume:121 Page:269-275
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Shah Sanket U.,Shields Carol L.,Bianciotto Carlos G.,Iturralde Juan,Al-Dahmash Saad A.,Say Emil Anthony T.,Badal Josep,Mashayekhi Arman,Shields Jerry A.

Funder

Eye Tumor Research Foundation

Publisher

Elsevier BV

Subject

Ophthalmology

Reference26 articles.

1. Classification and treatment of radiation maculopathy;Horgan;Curr Opin Ophthalmol,2010

2. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients;Shields;Arch Ophthalmol,2000

3. Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma: I. Visual acuity after 3 years COMS report no. 16;Collaborative Ocular Melanoma Study Group;Ophthalmology,2001

4. Early macular morphological changes following plaque radiotherapy for uveal melanoma;Horgan;Retina,2008

5. Vascular endothelial growth factor A in eyes with uveal melanoma;Missotten;Arch Ophthalmol,2006

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the effects of vitamin D analogs, bevacizumab, and radiotherapy in uveal melanoma cells;Experimental Eye Research;2024-11

2. Personalized treatment approaches in intraocular cancer;Advances in Ophthalmology Practice and Research;2024-08

3. Orbital cavernous venous malformation shrinkage during fractionated stereotactic radiotherapy contributing to the development of radiation retinopathy;European Journal of Ophthalmology;2024-06-07

4. Mouse model of radiation retinopathy reveals vascular and neuronal injury;Experimental Eye Research;2024-01

5. Radiation retinopathy;Retinal and Choroidal Vascular Diseases of the Eye;2024